Fig. 2From: Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective studyKaplan-Meier analysis of patient survival. Study groups did not significantly differ in Kaplan-Meier patient survival (P = 0.567 by log-rank test)Back to article page